MedPath

Role of Shubhdeep Swasha Hara Pill in management of Shwasa roga (Asthma)

Not Applicable
Not yet recruiting
Conditions
Moderate persistent asthma,
Registration Number
CTRI/2020/01/022961
Lead Sponsor
Self
Brief Summary

Tamaka Shwasa is a *Pittasthana Samudbhava* *Pranavaha Sroto Vikara,* in which *Avarudha marga* of *Pranavayu* due to morbid *Kapha* is the principle pathology involved. The vitiated *Doshas* afflicts *Rasa Dhatu*, involves *Pranavaha srotas* and produces the illness. Parallely, the signs & symptoms of  Tamaka Shwasa are closely related to Bronchial Asthma.Vata and Kapha are the two key pathological factors involved in the Samprapti of Tamaka Shwasa. Ayurveda has got many time tested formulations for this condition. According to line of treatment of Tamaka Shwasa the *Shubhdeep Swasha Hara Pill* is selected which contain ingredients which have *Vata-kapha hara* and *Ushna* property. It was prepared to provide better, palatable & cheap remedy for patients of Tamaka Shwasa. This study is carried out in one group with pre-test and post-test design where in a minimum 30 patients suffering from Tamaka Shwasa of either sex between the age group of 16 to 70 years will be selected for the study. Final assessment of result is made on the basis of subjective & objective criteria. Appropriate statistical tests will be applied for subjective and objective parameters obtained.

·

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1)Patients presenting with clinical features of Bronchial Asthma 2)Patients aged between 16-70 years with irrespective of gender 3)Peak Expiratory flow Rate more than 80 Lit/min & less than 300 Lit/min.

Exclusion Criteria

1)Patient aged less than 16 yr and more than 70 yrs 2)Peak Expiratory flow Rate less than 80 Lit/min are excluded 3)Asthma in pregnancy 4)Patients with severe attacks of Bronchial Asthma 5)Patients of Bronchial Asthma also suffering from other systemic disorders 6)The Bronchial asthma, associated with complications like emphysema and cor pulmonale.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Relief in breathlessness45th day
3) Relief in wheezing45th day
2) Relief in cough45th day
5) Reduced duration of attack of asthma45th day
6) Increase in Peak expiratory flow rate45th day
4) Reduced frequency of attacks of bronchial asthma45th day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shubhdeep ayurved medical college and hospital

🇮🇳

Indore, MADHYA PRADESH, India

Shubhdeep ayurved medical college and hospital
🇮🇳Indore, MADHYA PRADESH, India
Dr Akshiv garg
Principal investigator
9034386281
akshivgrg@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.